Ix Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

Ix Therapeutics General Information

Description

Developer of drugs for targeted discovery and early cancer detection intended to offer functional antibodies based on novel and proprietary targets. The company is engaged in therapeutic antibodies against colorectal and lung cancer, helping in individualizing the diagnosis and treatment of cancer and delivering truly personalized medicine to patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Falkenried 88, Building D
  • 20251 Hamburg
  • Germany
+49 040
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Falkenried 88, Building D
  • 20251 Hamburg
  • Germany
+49 040

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ix Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ix Therapeutics‘s full profile, request access.

Request a free trial

Ix Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ix Therapeutics‘s full profile, request access.

Request a free trial

Ix Therapeutics FAQs

  • When was Ix Therapeutics founded?

    Ix Therapeutics was founded in 2021.

  • Where is Ix Therapeutics headquartered?

    Ix Therapeutics is headquartered in Hamburg, Germany.

  • What industry is Ix Therapeutics in?

    Ix Therapeutics’s primary industry is Drug Discovery.

  • Is Ix Therapeutics a private or public company?

    Ix Therapeutics is a Private company.

  • What is Ix Therapeutics’s current revenue?

    The current revenue for Ix Therapeutics is .

  • Who are Ix Therapeutics’s investors?

    Indivumed Therapeutics and Xlife Sciences have invested in Ix Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process